Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States

Sadiq Y. Patel; Rozalina G. McCoy; Michael L. Barnett; Nilay D. Shah; Ateev Mehrotra

doi:10.1001/jamainternmed.2021.3047

July 6, 2021JAMA Internal MedicineOpen Access

Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States

View Full Paper

Ask AI

Bookmark

Share

Key Points

This study aims to compare diabetes care and health service rates for type 2 diabetes during the COVID-19 pandemic.
Cohort study design
Comparison of diabetes-related health services prior to and during the COVID-19 pandemic
Reduced rates of diabetes-related health services reported during the COVID-19 pandemic.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Cohort study compares diabetes care before and during COVID-19, indicating impacts on glycemic control.

Abstract

This cohort study compares rates at which patients with type 2 diabetes received diabetes-related health services prior to and during the COVID-19 pandemic.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Patel et al. (2021) studied this question.

synapsesocial.com/papers/6a61d4ff5a5e300a3289b051 https://doi.org/10.1001/jamainternmed.2021.3047

View Full Paper

Ask AI

Bookmark

Share

Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading